Market Outlook 14 minutes PremiumResearch Preview: Market Navigator—US Department Stores Sunny Zheng, Analyst October 11, 2023 What's InsideOur Market Navigator series offers in-depth, data-rich views of a retail, consumer or technology sector. This Research Preview provides an early look at our upcoming report on US department store retailing, in which we will explore the size and trajectory of the sector in 2023 and beyond, as well as critical factors impacting market growth. We also discuss e-commerce penetration, distribution channels, the competitive landscape, and key themes and innovators, as well as presenting blue-sky thinking for the sector. Data in this research report include: The size and year-over-year growth rates for the US department store sector for 2018–2027E The revenues of selected major US department stores for 2018–2022 Companies mentioned in this report include: Belk, Dillard’s, JCPenney, Kohl’s, Macy’s, Neiman Marcus Group, Nordstrom, Sacks Fifth Avenue Other relevant research: Market Navigator: US Retail and E-Commerce—Uncovering Opportunities in a Changing Landscape Market Outlook: Department Stores in China—Consumer Shift Toward E-Commerce Squeezes Sales Market Outlook: UK Department Stores—Slimmed Down and Shaping Up More reports in the Coresight Research Market Navigator (and Market Outlook) series Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Inflation Concerns Persist and Dollar Stores Thrive: US Consumer Survey Insights 2023, Week 43Roblox and Fortnite: Bridges to the Metaverse for Fashion BrandsSeptember 2023 US Retail Traffic and In-Store Metrics: Shopper Yield Decline Softens Despite Negative Trends in Store-Based Sales and TrafficA Focus on Value and Inclusivity via Generic Medications: Global Learnings in Healthcare